Sensitivity and Specificity of the Roth Test in Patients With COVID-19 Positive

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04832828

Enrollment

114

Registered

2021-04-06

Start date

2020-06-01

Completion date

2020-11-28

Last updated

2021-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19

Brief summary

The presence of the described silent hypoxia in subjects diagnosed with COVID19 highlights the need for valid tools to assess respiratory capacity. The Roth test has been associated with acceptable sensitivity and specificity criteria in patients with previous respiratory pathology; however, its validity in this type of patient has not been proven.

Interventions

DIAGNOSTIC_TESTRoth´s Test

Subjets must count from 1 to 30 in their languages, and health professional will count seconds that last in take breath during the count.

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

12 Years to 99 Years

Healthy volunteers

Inclusion criteria

1. having been diagnosed as COVID-19 positive and with symptoms compatible with Sars-Cov-2 infection in the last 7 days prior to assessment, 2. having an understanding of Spanish, 3. and having no history of respiratory pathology prior to the current infection.

Design outcomes

Primary

Measure	Time frame	Description
Oxygen Saturation	12 weeks	The pulseoximeter percentage value

Secondary

Measure	Time frame	Description
Roth´s test	12 weeks	The level described in the test

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026